文献速递心血管MR

左心室应变在临床前和显性肥厚型心肌病中异常:心脏磁共振特征追踪研究

Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
PubMed 文献 · Radiology · 2018-12-18

这项前瞻性多中心观察性研究纳入99名受试者(23名对照、34名临床前肥厚型心肌病、42名显性肥厚型心肌病),采用心脏磁共振特征追踪分析左心室心肌应变及环向透壁应变差(cTSD)。结果显示cTSD在对照组、临床前和显性肥厚型心肌病组分别为14%±4、17%±4和22%±7,所有比较P<.01;校正室间隔厚度和log转换N末端脑钠肽前体后,cTSD仍可预测临床前和显性肥厚型心肌病状态(P<.01)。

要点

  • 心脏磁共振特征追踪可检出临床前肥厚型心肌病(肌节突变携带者无左心室肥厚)的心肌收缩功能异常。
  • 环向透壁应变差(cTSD)在对照组、临床前和显性肥厚型心肌病组依次升高,所有比较P<.01。
  • 校正室间隔厚度和log转换N末端脑钠肽前体后,cTSD仍能预测临床前和显性肥厚型心肌病状态(P<.01)。

核心结论

  • 心脏磁共振特征追踪不仅能识别显性肥厚型心肌病的心肌功能障碍,还能在无左心室肥厚的肌节突变携带者中检出收缩异常,提示左心室壁厚度正常时已存在收缩功能异常。

研究设计与样本

  • 前瞻性、多中心、观察性研究(HCMNet),共纳入99名受试者(23名对照、34名临床前肥厚型心肌病、42名显性肥厚型心肌病),所有受试者均行基因检测,心脏磁共振时间分辨率≤40毫秒,采用特征追踪软件分析左心室心肌应变。

关键影像表现/征象

  • 最大左心室壁厚度在对照组为9.5 mm±1.4、临床前肥厚型心肌病组为9.8 mm±2.2(与对照组比较P=.496)、显性肥厚型心肌病组为16.1 mm±5.3(与对照组比较P<.001)。
  • 环向透壁应变差(cTSD)在对照组为14%±4、临床前肥厚型心肌病组为17%±4、显性肥厚型心肌病组为22%±7,所有比较P<.01。

诊断标准与关键数值

  • 环向透壁应变差(cTSD)定义为心外膜与心内膜环向应变之差。
  • 在校正年龄、性别及左心室参数的多项logistic回归模型中,cTSD可预测临床前和显性肥厚型心肌病状态(P<.01)。
  • 在控制室间隔厚度和log转换N末端脑钠肽前体的多变量模型中,cTSD仍可预测临床前和显性肥厚型心肌病状态(P<.01)。

临床应用与阅片要点

  • 采用心脏磁共振特征追踪测量环向透壁应变差(cTSD)有助于在左心室壁厚度正常的肌节突变携带者中识别临床前肥厚型心肌病。
  • cTSD在临床前和显性肥厚型心肌病中均升高,且独立于室间隔厚度和N末端脑钠肽前体预测疾病状态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate myocardial strain and circumferential transmural strain difference (cTSD; the difference between epicardial and endocardial circumferential strain) in a genotyped cohort with hypertrophic cardiomyopathy (HCM) and to explore correlations between cTSD and other anatomic and functional markers of disease status. Left ventricular (LV) dysfunction may indicate early disease in preclinical HCM (sarcomere mutation carriers without LV hypertrophy). Cardiac MRI feature tracking may be used to evaluate myocardial strain in carriers of HCM sarcomere mutation. Materials and Methods Participants with HCM and their family members participated in a prospective, multicenter, observational study (HCMNet). Genetic testing was performed in all participants. Study participants underwent cardiac MRI with temporal resolution at 40 msec or less. LV myocardial strain was analyzed by using feature-tracking software. Circumferential strain was measured at the epicardial and endocardial surfaces; their difference yielded the circumferential transmural strain difference (cTSD). Multivariable analysis to predict HCM status was performed by using multinomial logistic regression adjusting for age, sex, and LV parameters. Results Ninety-nine participants were evaluated (23 control participants, 34 participants with preclinical HCM [positive for sarcomere mutation and negative for LV hypertrophy], and 42 participants with overt HCM [positive for sarcomere mutation and negative for LV hypertrophy]). The average age was 25 years ± 11 and 44 participants (44%) were women. Maximal LV wall thickness was 9.5 mm ± 1.4, 9.8 mm ± 2.2, and 16.1 mm ± 5.3 in control participants, participants with preclinical HCM (P = .496 vs control participants), and participants with overt HCM (P < .001 vs control participants), respectively. cTSD for control participants, preclinical HCM, and overt HCM was 14% ± 4, 17% ± 4, and 22% ± 7, respectively (P < .01 for all comparisons). In multivariable models (controlling for septal thickness and log-transformed N-terminal brain-type natriuretic peptide), cTSD was predictive of preclinical and overt HCM disease status (P < .01). Conclusion Cardiac MRI feature tracking identifies myocardial dysfunction not only in participants with overt hypertrophic cardiomyopathy, but also in carriers of sarcomere mutation without left ventricular hypertrophy, suggesting that contractile abnormalities are present even when left ventricular wall thickness is normal. © RSNA, 2018 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Vigneault DM, Yang E, Jensen PJ, et al. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking. Radiology. 2018. PMID: 30561279. doi:10.1148/radiol.2018180339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。